Yonghong Li
Papers
1
Total Citations
5
H-Index
1
About
Dr. Yonghong Li is a pioneering researcher in plasmonic biosensing and cancer biomarker detection, whose work bridges nanotechnology and clinical diagnostics. Li’s key contributions center on developing universal plasmonic platforms that leverage monosaccharide-mediated synthesis to achieve broad spectral fluorescence enhancement—a breakthrough that dramatically improves the sensitivity of cancer biomarker analysis. Their most cited study, published in 2022, introduces a rational design strategy for creating highly stable, versatile nanostructures capable of amplifying fluorescent signals across a wide wavelength range, enabling the detection of oncological biomarkers in peripheral blood with unprecedented accuracy. This work, already garnering 5 citations, addresses a critical need for early cancer diagnosis by allowing localized tumors to be identified before metastasis. Li’s innovative approach not only enhances assay performance but also simplifies fabrication, making high-sensitivity screening more accessible for clinical settings. By integrating materials science with biomedical applications, Li has established a foundation for next-generation diagnostic tools that promise to transform cancer prognosis and patient outcomes—a testament to their vision of translating nanoscale engineering into real-world medical solutions.
Research Focus
Key Achievements
Top Papers
- 1